课题基金 / 基金详情

Studying epigenetic dysregulation in Down Syndrome using fluorescent reporter cell lines

Studying epigenetic dysregulation in Down Syndrome using fluorescent reporter cell lines
使用荧光报告细胞系研究唐氏综合症的表观遗传失调
批准号:
10432293
负责人:
ELLA ZELDICH
金额:
$8.25万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-03-01 至 2024-02-28

项目摘要

项目成果

ELLA ZELDICH的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Abstract: The exact etiology of the intellectual disability in Down syndrome (DS) is unknown. Triplication of human chromosome 21 (HSA21) results in widespread changes across the entire epigenome and transcriptome. Recent studies have identified dysregulated gene networks related to oligodendrocyte (OL) development, differentiation, and myelin maintenance in human and mouse DS brains. These transcriptional changes manifest in the delayed onset of myelination, reduced density of myelinated fibers, disruption in their lattice-like organization, and decreased conduction velocity across myelinated fibers, implying that aberrant gliogenesis and white matter alterations in trisomic brains contribute to intellectual deficits in DS. Furthermore, in contrast to the reduction of OLs, an expanded population of astrocytes has been reported in DS. OL cell specification and differentiation is tightly controlled through stage-specific acquisition of defined chromatin marks. Distinct epigenetic signatures, including differing patterns of DNA deacetylation and methylation, and altered histone marks have been observed in DS. Thus, the dysregulation of the genes driving OL development and maturation may be a consequence of aberrant DS-related epigenetic architecture resulting in perturbed OL production and the white matter deficit observed in DS. In our preliminary studies, we differentiated OLs from isogenic trisomic and euploid control induced pluripotent stem cells (iPSCs) derived from people with DS and identified trisomy-related dysregulation of OL commitment, development, and maturation. However, the heterogeneous culture inherent to the published protocol limits downstream analysis and identification of functionally and transcriptionally distinct OL subtypes as well as examination of their developmental trajectories in DS. Thus, our goal is to engineer two isogenic DS-derived iPSC lines to express tdTomato under the control of the endogenous platelet-derived growth factor receptor α (PDGFRα) locus to facilitate the study of the molecular etiology of the white matter deficit in DS. PDGFRα is primarily expressed in proliferating OPCs and PDGFRα+ progenitors, giving rise to mature OLs as well as astrocytes. Thus, DS-derived PDGFRα reporter lines will allow to examine changes in gliogenesis, the imbalance in OL and astrocyte production, and monitor OL development and maturation. Using these lines, we will perform single cell assay for transposase-accessible chromatin (ATAC)-seq to examine how changes in chromatin accessibility affect OL lineage developmental trajectory in DS patient-derived cells. Our studies will conceptually link DS-associated alterations in OL differentiation to the epigenetic architecture as the underlying cause for abnormal OL development leading to the intellectual deficits in DS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The contribution of X-chromosome-linked genes to cellular phenotypes and AD-related pathology in Down Syndrome
  • 批准号:
    10574254
  • 项目类别:
  • 资助金额:
    $24.75万
  • 财政年份:
    2022
  • 负责人:
    ELLA ZELDICH
  • 依托单位:
Studying Epigenetic Dysregulation in Down Syndrome Using Fluorescent Reporter Cell Lines
  • 批准号:
    10581695
  • 项目类别:
  • 资助金额:
    $8.25万
  • 财政年份:
    2022
  • 负责人:
    ELLA ZELDICH
  • 依托单位:
Development of myelinating oligodendrocytes in Down syndrome
  • 批准号:
    9975899
  • 项目类别:
  • 资助金额:
    $24.75万
  • 财政年份:
    2019
  • 负责人:
    ELLA ZELDICH
  • 依托单位:
海外基金